Sotera Health Q1 Earnings: Expectations High

Sotera Healths Q1 earnings, set to drop this Tuesday, are expected to show a 6.2% year-over-year revenue growth, up from 2.6% last year. Last quarter, they exceeded expectations with $303.4 million in sales, a 4.6% increase, and surpassed full-year guidance on earnings per share and revenue. Analysts have maintained their estimates, and Sotera has a history of outperforming Wall Street calls. In the life sciences tools and services space, peers have shown mixed results, but the sector is up 6% over the past month, with Sotera climbing 4.3%. Positive analyst sentiment is building, with an average price target of $20.50, well above the current $15.51 per share. Investors are optimistic about another potential win that could boost the stock in this hot sector. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/4c8791004c3e01b3